Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

Related Articles by Review for PubMed (Select 23365149)

1.

Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids.

Devogelaer JP, Sambrook P, Reid DM, Goemaere S, Ish-Shalom S, Collette J, Su G, Bucci-Rechtweg C, Papanastasiou P, Reginster JY.

Rheumatology (Oxford). 2013 Jun;52(6):1058-69. doi: 10.1093/rheumatology/kes410. Epub 2013 Jan 30.

PMID:
23365149
2.

The role of zoledronic acid in the management of osteoporosis.

Maricic M.

Clin Rheumatol. 2010 Oct;29(10):1079-84. doi: 10.1007/s10067-010-1486-3. Epub 2010 Jun 11. Review.

PMID:
20544246
3.

Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg.

Epstein S, Jeglitsch M, McCloskey E.

Curr Med Res Opin. 2009 Dec;25(12):2951-60. doi: 10.1185/03007990903361307. Review.

PMID:
19835464
4.

Zoledronic acid for prevention and treatment of osteoporosis.

Recknor C.

Expert Opin Pharmacother. 2011 Apr;12(5):807-15. doi: 10.1517/14656566.2011.562201. Epub 2011 Mar 9. Review.

PMID:
21385149
5.

[Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios].

Di Munno O, Delle Sedie A.

Reumatismo. 2011;63(2):67-79. Review. Italian.

PMID:
21776442
6.

Role of zoledronic acid in the prevention and treatment of osteoporosis.

Räkel A, Boucher A, Ste-Marie LG.

Clin Interv Aging. 2011;6:89-99. doi: 10.2147/CIA.S7282. Epub 2011 Mar 28. Review.

7.

[Randomized controlled trials for the prevention and treatment of glucocorticoid-induced osteoporosis].

Suzuki Y.

Clin Calcium. 2006 Nov;16(11):1834-42. Review. Japanese.

PMID:
17079850
8.

[Treatment of osteoporosis by risedronate-- speed, efficacy and safety].

Giljević Z, Vlak T.

Reumatizam. 2006;53(2):66-71. Review. Croatian.

PMID:
17580558
9.
10.

Once-yearly zoledronic acid in hip fracture prevention.

Demontiero O, Duque G.

Clin Interv Aging. 2009;4:153-64. Epub 2009 May 14. Review.

11.

Zoledronic acid: a review of its use in the treatment of osteoporosis.

Deeks ED, Perry CM.

Drugs Aging. 2008;25(11):963-86. doi: 10.2165/0002512-200825110-00007. Review.

PMID:
18947264
12.

Intravenous zoledronic acid for the treatment of osteoporosis.

Lewiecki EM.

Curr Osteoporos Rep. 2008 Mar;6(1):17-23. Review.

PMID:
18430396
13.

Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass.

Hamdy RC.

Drug Des Devel Ther. 2010 Nov 18;4:321-35. doi: 10.2147/DDDT.S6287. Review.

14.

Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis.

Bilezikian JP.

Am J Med. 2009 Feb;122(2 Suppl):S14-21. doi: 10.1016/j.amjmed.2008.12.003. Review.

PMID:
19187808
15.

Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis.

John Camm A.

Clin Ther. 2010 Mar;32(3):426-36. doi: 10.1016/j.clinthera.2010.03.014. Review.

PMID:
20399982
16.

Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease.

Bobba RS, Beattie K, Parkinson B, Kumbhare D, Adachi JD.

Drug Saf. 2006;29(12):1133-52. Review.

PMID:
17147460
17.

Glucocorticoid-induced osteoporosis.

Silverman SL, Lane NE.

Curr Osteoporos Rep. 2009 Mar;7(1):23-6. Review.

PMID:
19239826
18.

[Current topics over updating guidelines on the management and treatment of glucocorticoid-induced osteoporosis].

Suzuki Y.

Clin Calcium. 2014 Mar;24(3):417-24. doi: CliCa1403417424. Review. Japanese.

PMID:
24576939
19.

Bisphosphonates and glucocorticoid-induced osteoporosis: efficacy and tolerability.

Lespessailles E.

Joint Bone Spine. 2013 May;80(3):258-64. doi: 10.1016/j.jbspin.2012.08.005. Epub 2012 Sep 28. Review.

PMID:
23022421
20.

[Zoledronic acid reduces risk of any new clinical fracture and risk of death after surgical repair of a low-trauma hip fracture].

Leszczyński P.

Chir Narzadow Ruchu Ortop Pol. 2010 May-Jun;75(3):168-71. Review. Polish.

PMID:
21038635
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk